Clinical Trials Browser

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03815903 2019-07-18

INDUCTION

Phase 3 Unknown

434 enrolled

Other neoplasm

Locally Advanced Malignant Neoplasm

NCT00828386 2019-01-18

NPC2006

Phase 3 Terminated

83 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT01872962 2018-04-24

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Unknown

480 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03011060 2017-01-10

NACVCAC

Phase 3 Unknown

1,588 enrolled

Breast

Breast Neoplasm Female

NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Phase 2 Completed

455 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT02454647 2015-05-28

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Completed

46 enrolled

Gastrointestinal

Adenocarcinoma, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT02187315 2014-07-11

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

Phase 2 Unknown

160 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02096380 2014-03-26

The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Unknown

120 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01247493 2010-11-24

m-FLAI

Phase 2 Completed

108 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

MEND-IT II

Pre-CATALIS

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

KANALRAD

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

CONKO-007

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

MODEL

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

ICONA

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer

SRaIT

Treating NSCLC Minimal Stage IV With Curative Intent

Post Transplant Donor Lymphocyte Infusion

INDUCTION

NPC2006

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NACVCAC

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

m-FLAI